Allergan receives FDA approval for Botox to take care of overactive bladder The U.

Overactive bladder is normally a condition in which the bladder squeezes all too often or squeezes without warning. Symptoms include leaking urine , feeling the urgent and sudden have to urinate, and regular urination. When Botox is definitely injected into the bladder muscle, the bladder is caused by it to relax, increasing the bladder's storage capability and reducing episodes of urinary incontinence. Injecting the bladder with Botox is conducted using cystoscopy, an operation that allows a health care provider to visualize the inside of the bladder while Botox is being injected. Related StoriesAddressing quality of life needs in prostate tumor: an interview with Professor Louis DenisProtein sensor for proprioception foundExercise and chronic fatigue syndrome: an interview with Professor Trudie Chalder Clinical studies have demonstrated Botox's ability to significantly decrease the frequency of bladder control problems, said Hylton V.Tuberculosis. They will then disrupt the procedure at various points to see if indeed they can prevent disease in a mouse model. The work may lead to targets for a new class of antibiotics that could replace medications to which M. Tuberculosis have grown to be resistant. Arg-ello shall collaborate with Christopher Sassetti, PhD, assistant professor of molecular microbiology and genetics at the University of Massachusetts Medical College, who also works on M. Tuberculosis. Marsha Rolle, PhD, assistant professor of biomedical engineering, who will receive a two-calendar year, $215,962 NIH award to continue research aimed, ultimately, at the advancement of engineered replacement blood vessels.